九典制药拟以4658.45万元收购诺纳医药10%股权

Core Viewpoint - Jiutian Pharmaceutical plans to acquire an additional 10% stake in Hunan Nona Pharmaceutical Technology Co., Ltd. for 46.5845 million yuan to strengthen its control and strategic positioning in the biopharmaceutical sector [1] Group 1: Acquisition Details - The acquisition will increase Jiutian Pharmaceutical's ownership in Nona Pharmaceutical from 60% to 70% [1] - Nona Pharmaceutical will continue to be a subsidiary of Jiutian Pharmaceutical and will remain within the consolidated financial statements [1] Group 2: Strategic Implications - The acquisition is aimed at enhancing control over Nona Pharmaceutical, facilitating resource integration within the industry chain [1] - This move aligns with Jiutian Pharmaceutical's long-term development strategy to boost its competitiveness in the biopharmaceutical field [1]